Menu

Experience

Michael Tuscan

    • Sixth Street Invests in Blueprint Medicines 


    • Forbius Agrees to Sell to Bristol Myers Squibb 


    • Iconic Therapeutics Series C Financing 


    • FibroGen Closes Largest Biotech IPO in 12 Years 


    • T2 Biosystems IPO 


    • Adamas Pharmaceuticals Initial Public Offering 


    • Versartis $145 Million IPO 


    • First US IPO of 2014 for GlycoMimetics